Ubs Group Ag Stealth Bio Therapeutics Corp Transaction History

Ubs Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.2 - $0.32 $5,606 - $8,970	-28,032 Reduced 98.29%	487 $0
Q2 2022 Aug 10, 2022	BUY	$0.18 - $0.71 $4,849 - $19,127	26,940 Added 1706.14%	28,519 $7,000
Q1 2022 May 16, 2022	BUY	$0.49 - $0.9 $535 - $982	1,092 Added 224.23%	1,579 $1,000
Q3 2021 Nov 15, 2021	SELL	$1.17 - $1.58 $17,339 - $23,415	-14,820 Reduced 96.82%	487 $1,000
Q2 2021 Aug 13, 2021	BUY	$1.07 - $1.77 $11,274 - $18,650	10,537 Added 220.9%	15,307 $24,000
Q1 2021 May 12, 2021	BUY	$1.38 - $2.42 $5,634 - $9,880	4,083 Added 594.32%	4,770 $8,000
Q4 2020 Feb 11, 2021	SELL	$1.27 - $1.62 $9,036 - $11,526	-7,115 Reduced 91.19%	687 $1,000
Q3 2020 Nov 12, 2020	SELL	$1.32 - $2.23 $9,501 - $16,051	-7,198 Reduced 47.99%	7,802 $11,000
Q2 2020 Jul 31, 2020	BUY	$1.23 - $2.22 $17,958 - $32,412	14,600 Added 3650.0%	15,000 $27,000
Q1 2020 May 01, 2020	SELL	$0.97 - $3.13 $6,402 - $20,658	-6,600 Reduced 94.29%	400 $1,000
Q4 2019 Feb 14, 2020	BUY	$3.26 - $13.7 $932 - $3,918	286 Added 4.26%	7,000 $23,000
Q3 2019 Nov 14, 2019	BUY	$5.22 - $13.36 $24,184 - $61,896	4,633 Added 222.63%	6,714 $40,000
Q2 2019 Aug 14, 2019	BUY	$11.67 - $15.45 $23,526 - $31,147	2,016 Added 3101.54%	2,081 $26,000
Q1 2019 May 14, 2019	BUY	$11.75 - $18.01 $763 - $1,170	65 New	65 $1,000

2.94K

Ticker MITO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,548,600
Description
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.